Could Peloton Stock Deliver a 3-Bagger Comeback?
Remember when Peloton (NASDAQ: PTON) was the crown jewel of lockdown-era stocks? In early 2021, shares soared above $160, but today, it’s trading below $7.
The plunge may be the death knell for most stocks but here’s what might surprise most investors, beneath the wreckage, there are signs of a quiet but serious transformation.
» Read more about: Could Peloton Stock Deliver a 3-Bagger Comeback? »
Read More
When Will Walmart Join The Trillion Dollar Club?
At today’s $673 billion valuation, Walmart’s metrics track remarkably close to Microsoft’s pre-trillion phase, though through a distinctly retail-centric lens.
Where Microsoft achieved its milestone through software margins expanding from 28% to 35% over five years, Walmart charts its course through scale economics and business mix evolution, as evidenced by its operating margin expansion from 4.6% to 4.7% year-over-year.
» Read more about: When Will Walmart Join The Trillion Dollar Club? »
Read More
The Pet Care Powerhouse Flying Under Wall Street’s Radar
With the S&P 500 having advanced by about 23.7% year-to-date, deals among large-cap companies appear few and far between.
One stock that may be attractive, however, is Idexx Laboratories (NASDAQ:IDXX). This company specializes in veterinary diagnostic devices as well as poultry and livestock testing, among other animal-care essentials. Idexx also makes water testing supplies to monitor and maintain water quality.
» Read more about: The Pet Care Powerhouse Flying Under Wall Street’s Radar »
Read More
Major European Fintech with 36% Upside?
Euronet Worldwide (NASDAQ: EEFT) isn’t particularly well-known on US shores but it sits at the intersection of financial technology and the growing demand for cross-border transactions.
If you’re not already familiar with the firm it has a pretty diverse portfolio of financial technology services that encompass ATMs,
» Read more about: Major European Fintech with 36% Upside? »
Read More
Is This 8.6% Yield Too Good to Ignore?
If you’re the kind of investor who wants steady income, especially the kind that drops into your account every month like clockwork, the JPMorgan Equity Premium Income ETF (JEPI) is tough to ignore.
The headline number is eye-catching, an 8.6% trailing yield, paid monthly. That’s not just high, it’s more than four times the yield of the S&P 500 and well above what most high-grade corporate bonds are paying right now.
» Read more about: Is This 8.6% Yield Too Good to Ignore? »
Read MoreThe Burst
Why Buffett’s Buying This Beer Stock
In the second quarter, Warren Buffett quietly added nearly 1.4 million shares of Constellation Brands, bringing Berkshire Hathaway’s total stake to roughly just shy of $2 billion.
That’s a bold move at a time when the entire alcohol industry is facing a slump in consumption. But if history is any guide, Buffett tends to buy when sentiment is sour and value hides in plain sight.
» Read more about: Why Buffett’s Buying This Beer Stock »
Read MoreThe Ivy
Is PayPal About to Stage an AI-Powered Comeback
Shares of PayPal haven’t joined the tech sector’s rally. While the S&P 500 has climbed, PayPal has slipped about 15% over the past year. But a new partnership with OpenAI and strong underlying fundamentals could mark the start of a rebound.
Key Points
-
PayPal’s integration into ChatGPT positions it as the default payment option for AI-powered shopping—an early lead in conversational commerce.
» Read more about: Is PayPal About to Stage an AI-Powered Comeback »
Read MoreThe Daily
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
The approval of Novo Nordisk’s (NYSE:NVO)oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 market without requiring investors to choose one specific company.